Gilead Sciences, Inc. GILD NASDAQ

Gilead Sciences, Inc. (GILD) has shown moderate revenue growth over the past 3 years, expanding from $27.3B to $29.4B (average +2.6%/yr). Net income reached $8.5B, reflecting exceptional earnings expansion at +534.9%/yr on average. The net profit margin is 28.9%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 86.7% (high), with a +7.4pp trend over the period. With a $174B market cap and MOAT composite score of 90/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 35-year history, the company was profitable in 23 of 35 years — a mixed long-term record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (90/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 78/100 with 6/7 criteria passed.